These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 19447876)

  • 21. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
    Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
    J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
    Lee H; O'Meara SJ; O'Brien C; Kane R
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters.
    Stravodimos K; Constantinides C; Manousakas T; Pavlaki C; Pantazopoulos D; Giannopoulos A; Dimopoulos C
    Anticancer Res; 2000; 20(5C):3823-8. PubMed ID: 11268461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.
    Gonzalez-Moreno O; Lecanda J; Green JE; Segura V; Catena R; Serrano D; Calvo A
    Exp Cell Res; 2010 Feb; 316(4):554-67. PubMed ID: 20006606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.
    Sweeney C; Li L; Shanmugam R; Bhat-Nakshatri P; Jayaprakasan V; Baldridge LA; Gardner T; Smith M; Nakshatri H; Cheng L
    Clin Cancer Res; 2004 Aug; 10(16):5501-7. PubMed ID: 15328189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivin expression is associated with features of biologically aggressive prostate carcinoma.
    Shariat SF; Lotan Y; Saboorian H; Khoddami SM; Roehrborn CG; Slawin KM; Ashfaq R
    Cancer; 2004 Feb; 100(4):751-7. PubMed ID: 14770431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
    Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
    Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
    Fleischmann A; Schlomm T; Huland H; Köllermann J; Simon P; Mirlacher M; Salomon G; Chun FH; Steuber T; Simon R; Sauter G; Graefen M; Erbersdobler A
    Clin Cancer Res; 2008 Dec; 14(23):7838-42. PubMed ID: 19047112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Yeh YY; Chiao CC; Kuo WY; Hsiao YC; Chen YJ; Wei YY; Lai TH; Fong YC; Tang CH
    Biochem Pharmacol; 2008 Mar; 75(6):1292-301. PubMed ID: 18191107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
    Moul JW; Maygarden SJ; Ware JL; Mohler JL; Maher PD; Schenkman NS; Ho CK
    J Urol; 1996 Mar; 155(3):982-5. PubMed ID: 8583622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
    Maeda M; Johnson KR; Wheelock MJ
    J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: correlation with histopathologic effects and biochemical recurrence.
    Miyata Y; Sakai H; Kanda S; Igawa T; Hayashi T; Kanetake H
    Urology; 2004 Jun; 63(6):1184-90. PubMed ID: 15183987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.